Establishment of a chimeric, replication-deficient influenza A virus vector by modulation of splicing efficiency

Journal of Virology

Volumn 85, Issue 5, 2011, Pages 2469-2473

  Wolschek, Markus ^a,b   Samm, Elisabeth ^a,b   Seper, Helena ^b   Sturlan, Sanda ^a,b   Kuznetsova, Irina ^a   Schwager, Cornelia ^a,b   Khassidov, Alexandra ^a,b   Kittel, Christian ^b,c   Muster, Thomas ^b   Egorov, Andrej ^b   Bergmann, Michael ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Avir Green Hills Biotechnology AG   (Austria)

^c BAXTER INNOVATIONS GMBH   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CHEMOKINE; IMMUNOGLOBULIN KAPPA CHAIN; INTEIN; INTERLEUKIN 2; MESSENGER RNA; NONSTRUCTURAL PROTEIN 1; NONSTRUCTURAL PROTEIN 2; SIGNAL PEPTIDE; VIRUS VECTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; CHIMERA; CONTROLLED STUDY; GENE EXPRESSION; GENETIC STABILITY; INFLUENZA VIRUS A; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; RNA SEQUENCE; RNA SPLICING; START CODON; TRANSLATION INITIATION; VIRUS REPLICATION;

DEFECTIVE VIRUSES; GENE EXPRESSION; GENETIC VECTORS; INFLUENZA A VIRUS; RNA SPLICING; VIRUS REPLICATION;

INFLUENZA A VIRUS;

EID: 79551708183     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01650-10     Document Type: Article

References (31)

1. Aragon, T., et al. 2000. Eukaryotic translation initiation factor 4GI is a cellular target for NS1 protein, a translational activator of influenza virus. Mol. Cell. Biol. 20:6259-6268.
2. Bendtsen, J. D., H. Nielsen, G. von Heijne, and S. Brunak. 2004. Improved prediction of signal peptides: SignalP 3.0. J. Mol. Biol. 340:783-795.
3. Davis, L. S., P. E. Lipsky, and K. Bottomly. 2001. Measurement of human and murine interleukin 2 and interleukin 4. Curr. Protoc. Immunol. 2001: Unit 6.3.
4. Egorov, A., et al. 1998. Transfectant influenza A viruses with long deletions in the NS1 protein grow efficiently in Vero cells. J. Virol. 72:6437-6441. (Pubitemid 28323956)
5. Freund, M., et al. 2005. Extended base pair complementarity between U1 snRNA and the 5′ splice site does not inhibit splicing in higher eukaryotes, but rather increases 5′ splice site recognition. Nucleic Acids Res. 33:5112-5119. (Pubitemid 41487819)
6. Garaigorta, U., and J. Ortin. 2007. Mutation analysis of a recombinant NS replicon shows that influenza virus NS1 protein blocks the splicing and nucleo-cytoplasmic transport of its own viral mRNA. Nucleic Acids Res. 35:4573-4582. (Pubitemid 47250332)
7. García-Sastre, A., et al. 1998. Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 252:324-330. (Pubitemid 29013414)
8. García-Sastre, A., T. Muster, W. S. Barclay, N. Percy, and P. Palese. 1994. Use of a mammalian internal ribosomal entry site element for expression of a foreign protein by a transfectant influenza virus. J. Virol. 68:6254-6261. (Pubitemid 24294875)
9. Hoffmann, E., G. Neumann, Y. Kawaoka, G. Hobom, and R. G. Webster. 2000. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc. Natl. Acad. Sci. U. S. A. 97:6108-6113.
10. Kittel, C., et al. 2005. Generation of an influenza A virus vector expressing biologically active human interleukin-2 from the NS gene segment. J. Virol. 79:10672-10677. (Pubitemid 41098606)
11. Kittel, C., et al. 2004. Rescue of influenza virus expressing GFP from the NS1 reading frame. Virology 324:67-73. (Pubitemid 38737400)
12. Lamb, R. A., P. W. Choppin, R. M. Chanock, and C. J. Lai. 1980. Mapping of the two overlapping genes for polypeptides NS1 and NS2 on RNA segment 8 of influenza virus genome. Proc. Natl. Acad. Sci. U. S. A. 77:1857-1861.
13. Machado, A. V., N. Naffakh, S. van der Werf, and N. Escriou. 2003. Expression of a foreign gene by stable recombinant influenza viruses harboring a dicistronic genomic segment with an internal promoter. Virology 313:235-249. (Pubitemid 37013607)
14. Manicassamy, B., et al. 2010. Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus. Proc. Natl. Acad. Sci. U. S. A. 107:11531-11536.
15. Marion, R. M., T. Aragon, A. Beloso, A. Nieto, and J. Ortin. 1997. The N-terminal half of the influenza virus NS1 protein is sufficient for nuclear retention of mRNA and enhancement of viral mRNA translation. Nucleic Acids Res. 25:4271-4277. (Pubitemid 27485205)
16. Martínez-Sobrido, L., and A. García-Sastre. 2007. Recombinant influenza virus vectors. Future Virol. 2:401-416. (Pubitemid 47050234)
17. Mollenhauer, H. H., D. J. Morre, and L. D. Rowe. 1990. Alteration of intracellular traffic by monensin; mechanism, specificity and relationship to toxicity. Biochim. Biophys. Acta 1031:225-246.
18. Muster, T., et al. 2004. Interferon resistance promotes oncolysis by influenza virus NS1-deletion mutants. Int. J. Cancer 110:15-21. (Pubitemid 38507199)
19. Nemeroff, M. E., U. Utans, A. Kramer, and R. M. Krug. 1992. Identification of cis-acting intron and exon regions in influenza virus NS1 mRNA that inhibit splicing and cause the formation of aberrantly sedimenting presplicing complexes. Mol. Cell. Biol. 12:962-970.
20. Nicolson, C., D. Major, J. M. Wood, and J. S. Robertson. 2005. Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system. Vaccine 23:2943-2952.
21. Nylander, S., and I. Kalies. 1999. Brefeldin A, but not monensin, completely blocks CD69 expression on mouse lymphocytes: efficacy of inhibitors of protein secretion in protocols for intracellular cytokine staining by flow cytometry. J. Immunol. Methods 224:69-76. (Pubitemid 29273982)
22. Percy, N., W. S. Barclay, A. García-Sastre, and P. Palese. 1994. Expression of a foreign protein by influenza A virus. J. Virol. 68:4486-4492. (Pubitemid 24183044)
23. Plotch, S. J., and R. M. Krug. 1986. In vitro splicing of influenza viral NS1 mRNA and NS1-beta-globin chimeras: possible mechanisms for the control of viral mRNA splicing. Proc. Natl. Acad. Sci. U. S. A. 83:5444-5448.
24. Restifo, N. P., et al. 1998. Transfectant influenza A viruses are effective recombinant immunogens in the treatment of experimental cancer. Virology 249:89-97. (Pubitemid 28430910)
25. Robb, N. C., D. Jackson, F. T. Vreede, and E. Fodor. 2010. Splicing of influenza A virus NS1 mRNA is independent of the viral NS1 protein. J. Gen. Virol. 91:2331-2340.
26. Ruskin, B., A. R. Krainer, T. Maniatis, and M. R. Green. 1984. Excision of an intact intron as a novel lariat structure during pre-mRNA splicing in vitro. Cell 38:317-331.
27. Salvatore, M., et al. 2002. Effects of influenza A virus NS1 protein on protein expression: the NS1 protein enhances translation and is not required for shutoff of host protein synthesis. J. Virol. 76:1206-1212. (Pubitemid 34066424)
28. + Th1 immune response and protect animals against tuberculosis challenge. Clin. Vaccine Immunol. 13:898-904.
29. Shih, S. R., M. E. Nemeroff, and R. M. Krug. 1995. The choice of alternative 5′ splice sites in influenza virus M1 mRNA is regulated by the viral polymerase complex. Proc. Natl. Acad. Sci. U. S. A. 92:6324-6328.
30. Talon, J., et al. 2000. Influenza A and B viruses expressing altered NS1 proteins: a vaccine approach. Proc. Natl. Acad. Sci. U. S. A. 97:4309-4314.
31. Wacheck, V., et al. 2010. A novel type of influenza vaccine: safety and immunogenicity of replication-deficient influenza virus created by deletion of the interferon antagonist NS1. J. Infect. Dis. 201:354-362.